Harvey Norman Holdings Limited
HNORY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.18 | -0.47 | -0.23 | -1.62 |
| FCF Yield | 10.79% | 8.59% | 11.52% | 8.68% |
| EV / EBITDA | 6.35 | 9.27 | 5.77 | 5.34 |
| Quality | ||||
| ROIC | 3.65% | 3.24% | 4.66% | 7.87% |
| Gross Margin | 50.96% | 50.76% | 48.67% | 51.07% |
| Cash Conversion Ratio | – | 1.95 | 1.26 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.14% | -1.82% | -1.34% | 21.77% |
| Free Cash Flow Growth | 3.31% | 0.36% | -1.95% | 13.26% |
| Safety | ||||
| Net Debt / EBITDA | 1.90 | 2.40 | 1.81 | 1.19 |
| Interest Coverage | 3.44 | 3.25 | 5.18 | 14.06 |
| Efficiency | ||||
| Inventory Turnover | 3.22 | 3.46 | 3.75 | 3.87 |
| Cash Conversion Cycle | 143.01 | 138.12 | 141.53 | 141.63 |